Company: INDP
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001641172-25-010099
Chunk: 66

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 2
Chunk 66
---
 $0.06 million and are due in the next twelve
months. For additional details regarding our lease, see Note 7 to our unaudited condensed consolidated financial statements included
in this Quarterly Report.

We
did not have during the periods presented, and we do not currently have any off-balance sheet arrangements, as defined under the SEC
rules.

Critical
Accounting Policies

This
discussion and analysis of our financial condition and results of operations is based on our unaudited condensed consolidated financial
statements, which have been prepared in accordance with U.S. GAAP. The preparation of these unaudited condensed consolidated financial
statements requires us to make estimates that affect the reported amounts of our assets, liabilities and expenses. Significant accounting
policies employed, including the use of estimates, are presented in the notes to our annual financial statements included in our 2024
Annual Report on Form 10-K. We periodically evaluate our estimates, which are based on historical experience and on various other assumptions
that we believe to be reasonable under the circumstances. Critical accounting policies are those that are most important to the portrayal
of our financial condition and results of operations and require our subjective or complex judgments, resulting in the need to make estimates
about the effect of matters that are inherently uncertain. If actual performance should differ from historical experience or if the underlying
assumptions were to change, our financial condition and results of operations may be materially impacted.

Our
critical accounting policies are described under the heading “Management’s Discussion and Analysis of Financial Condition
and Results of Operations—Critical Accounting Policies” in our 2024 Annual Report on Form 10-K. During the three months ended
March 31, 2025, there were no material changes to our critical accounting policies from those discussed in our 2024 Annual Report on
Form 10-K.

Recently
Issued Accounting Pronouncements

In
November 2024, the FASB issued ASU No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures.
This ASU will require entities to provide enhanced disclosures, in a tabular format, related to certain expense categories included in
the statement of operations. The ASU aims to increase transparency and provide investors with more detailed information about the nature
of expenses reported on the face of the income statement. The new ASU is effective for annual reporting periods beginning after December
15, 2026 and interim reporting periods beginning after December 15, 2027.